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Introduction: Sepsis and other infections are associated with late cardiovascular events. Although persistent
inflammation is implicated, a causal relationship has not been established. We tested whether sepsis causes vascular
inflammation and accelerates atherosclerosis.
Methods: We performed prospective, randomized animal studies at a university research laboratory involving adult
male ApoE-deficient (ApoE−/−) and young C57B/L6 wild-type (WT) mice. In the primary study conducted to determine
whether sepsis accelerates atherosclerosis, we fed ApoE−/− mice (N = 46) an atherogenic diet for 4 months and then
performed cecal ligation and puncture (CLP), followed by antibiotic therapy and fluid resuscitation or a sham operation.
We followed mice for up to an additional 5 months and assessed atheroma in the descending aorta and root of the
aorta. We also exposed 32 young WT mice to CLP or sham operation and followed them for 5 days to determine the
effects of sepsis on vascular inflammation.
Results: ApoE−/− mice that underwent CLP had reduced activity during the first 14 days (38% reduction compared to
sham; P < 0.001) and sustained weight loss compared to the sham-operated mice (−6% versus +9% change in weight
after CLP or sham surgery to 5 months; P < 0.001). Despite their weight loss, CLP mice had increased atheroma (46% by
3 months and 41% increase in aortic surface area by 5 months; P = 0.03 and P = 0.004, respectively) with increased
macrophage infiltration into atheroma as assessed by immunofluorescence microscopy (0.52 relative fluorescence units
(rfu) versus 0.97 rfu; P = 0.04). At 5 months, peritoneal cultures were negative; however, CLP mice had elevated serum
levels of interleukin 6 (IL-6) and IL-10 (each at P < 0.05). WT mice that underwent CLP had increased expression of
intercellular adhesion molecule 1 in the aortic lumen versus sham at 24 hours (P = 0.01) that persisted at 120 hours
(P = 0.006). Inflammatory and adhesion genes (tumor necrosis factor α, chemokine (C-C motif) ligand 2 and vascular cell
adhesion molecule 1) and the adhesion assay, a functional measure of endothelial activation, were elevated at 72 hours
and 120 hours in mice that underwent CLP versus sham-operations (all at P <0.05).
Conclusions: Using a combination of existing murine models for atherosclerosis and sepsis, we found that CLP, a
model of intra-abdominal sepsis, accelerates atheroma development. Accelerated atheroma burden was associated
with prolonged systemic, endothelial and intimal inflammation and was not explained by ongoing infection. These
findings support observations in humans and demonstrate the feasibility of a long-term follow-up murine model of
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Several studies have suggested a link between acute car-
diovascular events (such as cardiac event–related death,
acute myocardial infarction and stroke) and prior infec-
tion [1-4]. However, a lack of detailed measures of car-
diovascular disease burden prior to the occurrence of
infection, particularly subclinical disease, has the poten-
tial to confound the interpretation of these studies [1-3].
Furthermore, the mechanisms underlying this associ-
ation are unclear. Ongoing infection in vessel walls was
first thought to be the cause of accelerated atheroscler-
osis, but this link has never been established [4]. We
previously demonstrated that human sepsis survivors
often have persistent inflammation after the infection
has resolved, which is associated with an increased risk
of subsequent cardiovascular death [5]. We therefore hy-
pothesized that sepsis may lead to persistent vascular in-
flammation, which in turn could accelerate the growth
or destabilization of atheromatous plaques. In other
words, we hypothesized that the dysregulated immune
response characteristic of sepsis may have a persistent
“tail” that accelerates the progression of underlying car-
diovascular disease [6].
We wished to test this hypothesis in experimental ani-
mal models by using a combination of existing murine
models of atherosclerosis and sepsis. Our work was fo-
cused on both short- and long-term effects of sepsis, in
contrast to prior studies that focused only on short-term
inflammatory changes following viral infections [7].
Material and methods
Study overview
In our primary experiment, we assessed whether sepsis has
long-term effects on physical function, systemic inflamma-
tion and atheroma in animals with preexisting cardiovascu-
lar disease. To mimic chronic preexisting cardiovascular
disease, we used the well-established model of ApoE-
deficient (ApoE−/−) mice fed an atherogenic diet for
16 weeks [8]. In this model, atheroma burden in the aorta
is considered a mimic of human coronary artery disease.
To mimic sepsis, we then performed cecal ligation and
puncture (CLP), a well-established model of sepsis [9]. We
gave these mice intraperitoneal fluids and antibiotics to
mimic clinical practice and adjusted the needle size in pilot
experiments until the day 7 lethality was low. We then ran-
domly assigned 46 atherogenic diet–fed ApoE−/− mice to
the CLP or sham operation group and followed them
for up to 5 months. We monitored weight and physical
activity over time and killed the animals at select time
points to assess circulating inflammatory markers and
atheroma burden via aortic morphometry, histology
and immunofluorescent staining for macrophages. In a
secondary experiment, we exposed 32 young wild-type
(WT) mice to CLP or a sham operation with 5-dayfollow-up to determine the immediate effects of sepsis
on aortic wall inflammation (Figure 1). All aspects of
this study complied with the Guide for the Care and
Use of Laboratory Animals published by the National
Institutes of Health (NIH Publication 85-23 (revised
1996)) and met the approval of the Institutional Animal
Care and Use Committee of the University of Pittsburgh
(IACUC 1110706B-2).
Primary experimental protocol: atherosclerosis in ApoE−/−
mice followed by CLP or sham surgery
We first conducted pilot studies to establish the com-
bined model. To generate a model of atherosclerosis, we
obtained 6- to 8-week-old male ApoE−/− mice on a
C57BL/6 background from The Jackson Laboratory (Bar
Harbor, ME, USA), housed them in pathogen-free rooms
and fed them a standard atherogenic Western diet
(Teklad TD.88137; Harlan Laboratories, Indianapolis,
IN, USA) for 16 weeks [10]. We killed 8 animals after
16 weeks and confirmed that there were macroscopic-
ally visible atherosclerotic lesions in the aortic root and
descending aorta. These plaques were yellowish-white
in appearance, projected into the lumen of the aorta
and were more abundant in the arch of the aorta as
well as in the iliac arteries, sites of turbulent flow. To
generate a model of sepsis that mimicked the clinical
scenario of severe infection from which animals had a
strong likelihood of surviving with supportive care, we
pilot-tested alternative needle sizes and supportive care
strategies in the ApoE−/− atherogenic diet–fed mice. In
the final pilot in 16 mice, we used a 25-gauge needle
with a single perforation, followed by fluid resuscitation
and antibiotics at 12, 36 and 60 hours after the surgery.
This led to notable limitation of physical activity (see
Additional file 1). Only one animal died by day 7.
Following the pilot phase, we randomized forty-six 22-
to 24-week-old, atherogenic diet–fed ApoE−/− mice to
the sham operation or CLP group (Figure 1). For sham
or CLP surgery, mice received intraperitoneal anesthesia
with ketamine (85 mg/kg) and xylazine (13 mg/kg). We
performed a left-sided abdominal paramedian vertical in-
cision (about 2 cm). In the sham-operated group, we
mobilized the cecum and then closed the abdomen. In
the CLP group, we mobilized the cecum, ligated ap-
proximately 40% of its length from the base without
compromising the blood flow, and punctured with a 25-
gauge needle. A small amount of fecal contents were
expressed, then the cecum was placed back into the
peritoneum and the abdomen was closed in layers. A
single operator performed all of the surgical procedures
to eliminate interoperator variability. We then injected
1 ml of sterile warm saline intraperitoneally to both
groups. Both groups of mice received intraperitoneal
imipenem-cilastatin (Merck, Whitehouse Station, NJ,
Figure 1 Time scale of the experimental protocol. In the primary experimental protocol, a sepsis survival program was designed in apolipoprotein
E–deficient mice fed a high-fat diet prior to the surgical intervention. In the secondary acute model, the wild-type mice were fed a regular diet until the
time of surgery. CCL2, Chemokine (C-C motif) ligand 2; ICAM-1, Intercellular adhesion molecule 1; IL, Interleukin; MCP-1, Monocyte chemotactic protein 1;
TNF-α, Tumor necrosis factor α; VCAM-1, Vascular cell adhesion molecule 1.
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60 hours after the surgery. All mice received diet, water
and DietGel (ClearH2O, Portland, ME, USA) ad libitum
and were monitored at least twice daily.
Mice were killed per protocol on day 1 and at 3 and
5 months to obtain aortic tissue samples and blood for
circulating inflammatory markers (Figure 1). We decided
on these time points based on previously published lit-
erature suggesting a progressive increase in atheroscler-
osis in ApoE−/− mice over the course of 6 months [11].
We killed 16 animals (8 per group) on day 1, 13 (6 in
the CLP group and 7 sham-operated) at 3 months and
the remainder (9 in the CLP group and 8 sham-
operated) at 5 months. Of note, animals would be killed
early if they became moribund. However, all animals
reached the per-protocol time points.
Clinical parameters
Following sham or CLP surgery in ApoE−/− mice, we
measured body weight and activity at days 0, 1, 2, 7 and14 using a score previously validated by Zantl et al.
[12-14]. The score is a composite index of overall well-
being of septic mice. The index is composed of fur qual-
ity, weight change, baseline and evoked activity as a
surrogate for disease severity, used both during the pilot
and actual experiments. It was not possible to blind the
assessments, as the CLP mice had an obvious decrease
in physical activity.
Aortic histology and morphometry to study progression of
atheroma
We conducted histologic and morphometric assessments
of the descending aorta and aortic root to assess athero-
sclerotic burden in ApoE−/− mice. We flushed the arter-
ial system with cold phosphate-buffered saline (PBS) via
the left ventricle, excised aortae from the arch to the
iliac bifurcation and placed them in cold PBS. We re-
moved adventitial fat and opened aortae longitudinally.
To determine atheroma in the descending aorta, we next
placed dissected aortae in 70% ethanol and stained the
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Louis, MO, USA) and mounted them en face in glycerol-
gelatin mounting medium on a polymer board (Sigma-
Aldrich). We scanned the aortae with an Olympus
macroscope (Olympus, Center Valley, PA, USA), ana-
lyzed them using MetaMorph (Molecular Devices, Sun-
nyvale, CA, USA) and calculated atheroma burden as
the percentage of total aortic area. To determine aortic
root atheroma, we obtained 7-μm-thick sections and
stained them with hematoxylin and eosin for structural
morphology, oil red O for atheroma burden and Sirius
Red for fibrillar collagen. To measure both descending
and root aorta plaque sizes, we used MetaMorph
computer-assisted image analysis software to determine
stained areas with consistent thresholds across all the
image fields. Because the descending aorta was intact,
we expressed atheroma as the percentage of total sur-
face area. For the aortic root, which was analyzed
cross-sectionally, we present data as both absolute
values and adjusted for mouse weight [10].
We determined the topographic relationship between
atheroma progression and macrophages in ApoE−/− mice
using immunofluorescent staining with Mac-3 antibody.
We focused on the macrophages because macrophages
play an important role in sepsis and atherosclerosis [15].
We fixed the aortic root and ascending aorta in 2% para-
formaldehyde in PBS for 2 hours, placed them in 30%
sucrose for 24 hours, embedded them in optimal cutting
temperature (OCT) compound, stored them at −80°C
and sectioned them (7 μm) with a cryostat. Prior to
blocking nonspecific binding sites, we permeabilized
samples in 0.1% Triton X-100 in PBS for 10 minutes and
then washed them in PBS. Tissues were quenched with
H2O2 for 10 minutes at room temperature and then
blocked for nonspecific binding with 2% bovine serum
albumin (BSA) for 1 hour. We detected macrophages
using rat monoclonal anti-mouse Mac-3 antibody (1:100,
clone M3/84; BD Biosciences, San Diego, CA, USA).
Secondary antibody mixtures of horse anti-mouse im-
munoglobulin G (IgG) coupled to Texas Red and goat
anti-rabbit IgG conjugated with fluorescein isothiocyan-
ate (FITC) were used. To correlate the localization of
different antigens and connective tissue components, we
took images of the same microscopic fields with each fil-
ter set (FITC, Texas Red and 4′,6-diamidino-2-phenylin-
dole dihydrochloride (DAPI)) and merged them using
MetaMorph software.
Circulating inflammatory cytokines
To determine whether inflammation persists during re-
covery, we measured serum tumor necrosis factor α
(TNF-α), interleukin 6 (IL-6), IL-10 and monocyte
chemotactic protein 1 (MCP-1) on day 1 and at 3 and
5 months after sham or CLP surgery in ApoE−/− mice.Cytokines were measured with multiplex bead-based
Luminex assays (R&D Systems, Minneapolis, MN, USA)
and analyzed with a Bio-Plex™ 200 instrument and Bio-
Plex™ Manager software (Bio-Rad Laboratories, Hercules,
CA, USA). The lower limits of detection for the inflamma-
tory cytokines were as follows: TNF-α, 2.52 pg/ml; IL-6:
3.48 pg/ml; IL-10: 2.67 pg/ml; and MCP-1, 2.21 pg/ml.
Secondary experimental protocol: aortic wall inflammation
in young WT C57BL/6 mice following CLP or sham surgery
To understand whether sepsis has acute inflammatory
effects on vessel walls, we also conducted a simpler
model of CLP with short follow-up in WT animals re-
ceiving a regular diet without prior induction of ather-
oma. Using thirty-two 6- to 8-week-old male C57BL/6
WT mice, we administered the same animal housing
protocol, CLP or sham procedures and sample collection
as we used in ApoE−/− mice. We killed 6 animals (three in
each group) on day 1, 16 (7 CLP and 9 sham-operated
mice) on day 3 and the remainder (4 CLP and 6 sham-
operated mice) on day 5.
To explore aortic inflammation in the early phases of
sepsis, we examined protein and mRNA expression of in-
flammatory markers (MCP-1 and TNF-α) and adhesion
molecules (intercellular adhesion molecule 1 (ICAM-1)
and vascular cell adhesion molecule 1 (VCAM-1)) and
endothelial activation in the aorta on days 1, 3, and 5 after
sham or CLP surgery in WT mice. We focused on these
markers because they play an important role in athero-
sclerosis [16].
To compare inflammatory marker and adhesion mol-
ecule protein expression (VCAM-1, ICAM-1, TNF-α
and MCP-1), we used immunofluorescent staining. We
cut the ascending aorta away from the heart at an angle
to include the aortic valve, placed it into 2% paraformal-
dehyde in PBS for 2 hours and then put it into a 30% su-
crose solution for 24 hours. Next, we embedded aortic
tissues in OCT compound, maintained them at −80°C
and transversely cut (7 μm thick) them to include the
aortic valves. The frozen sections were then left to dry at
room temperature for 30 minutes. Once dried, the slides
were placed into a 2% BSA solution at room temperature
for 1 hour. Following the 1-hour blocking step, the tissues
were incubated with ICAM-1 (1:100, AF796; R&D Sys-
tems) and VCAM-1 (1:50, 14-1061-81; eBioscience, San
Diego, CA, USA) in a 0.5% BSA solution at 4°C overnight.
All of the subsequent incubations were performed at
room temperature. The primary antibodies were washed
thoroughly with PBS, and the secondary antibodies (anti-
goat Alexa Fluor 488 and anti-rat Alexa Fluor 594; 1:500)
were each incubated in a 0.5% BSA solution for 1 hour.
The slides were washed with PBS and mounted in
VECTASHIELD mounting medium (Vector Laboratories,
Burlingame, CA, USA) containing DAPI as a nuclear
Figure 2 Change in body weight and activity composite score
over the course of 5 months in the primary experimental
protocol, chronic sepsis survival model. The analysis was
performed in animals that underwent sham or cecal ligation and
puncture (CLP) surgery (six per time point and nine per time point,
respectively) and analyzed by two-way analysis of variance (*P < 0.001).
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microscope (Nikon Instruments, Melville, NY, USA).
We performed RT-PCR to study gene expression for
inflammatory markers and adhesion molecules (VCAM-
1, ICAM-1, TNF-α and chemokine (C-C motif ) ligand 2
(CCL2)) in the aortic arch. The correlation between the
locations of atherosclerotic lesions and regions of dis-
turbed flow is well documented for the aortic arch, and
the murine aortic arch has flow dynamics and gene ex-
pression patterns similar to human aortic arch tissues
[15,17,18]. Aortic arches were homogenized in TRIzol
reagent, and total RNA was extracted according to the
manufacturer’s instructions (Ambion, Austin, TX, USA).
RNA yield from individual mice was 0.6 to 1.0 μg per
aortic arch. Single-stranded cDNA was synthesized using
the High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Foster City, CA, USA), and RT-
PCR was then performed using TaqMan Universal PCR
Master Mix (Applied Biosystems). The reaction volume
(25 μl) consisted of 12.5 μl of 2× TaqMan Universal
PCR Master Mix, 1 μl of cDNA and 1.25 μl of 20× 6-
carboxyfluorescein-labeled TaqMan Gene Expression
Assay Master Mix solution. For the real-time PCRs of
the genes (VCAM-1, ICAM-1, CCL2, TNF-α and β-actin),
the TaqMan inventoried Assays-on-Demand Gene Expres-
sion products were purchased from Applied Biosystems.
The fold difference in expression of target cDNA was de-
termined using the comparative threshold cycle method
as described previously [19]. The primers used were as fol-
lows: VCAM-1: ATGCACCAAGTACAAAGTCAGC and
TTGGTCGAACTCAGGATTAGC (202 bp); ICAM-1: C
TGAACATCCCATGACCTTCC and GCCCAAGGACA
TATTCACAGC (209 bp); CCL2: TGACCAGTGCCCATGA
CAAGC and CATTGTTCCCGTGCATCAAAGG (229 bp);
TNF-α: TACCAGCTCCCAAAATCCTG and TCTGC
TAATTCCAGCCTCGT (152 bp); β-actin: GTGATCC
CTGGGCCTGGTG and GGAAACGAATACACGGTG
ATGG (278 bp).
To explore early endothelial activation, we used an
ex vivo monocyte adhesion assay. We dissected the de-
scending aorta from the arch to the iliac bifurcation and
placed it into complete cell culture medium containing
Dulbecco’s modified Eagle’s medium with 10% fetal bo-
vine serum. We used RAW-Blue cells (InvivoGen, San
Diego, CA, USA) as the monocyte cell line to observe ad-
hesion, and cells between passages 6 and 15 were used.
RAW-Blue cells were labeled with the acetomethoxy de-
rivative of calcein (1 μM), and adhesion to the mouse aorta
was carried out as described previously [20,21]. Photo-
graphs were taken using a fluorescence macroscope (Carl
Zeiss, Thornwood, NY, USA), and the number of macro-
phages that adhered to the mouse aorta were counted
using the MetaMorph imaging analysis system (Molecular
Devices) and normalized to the total aortic area.Statistical analysis
Data are presented as mean ± SD. Statistical analysis was
carried out using two-way analysis of variance for weight
changes and activity for continuous variables, and a non-
parametric Mann-Whitney U test was used for the other
parameters measured. We defined statistical significance
as P < 0.05.
Results
Long-term clinical effects of sepsis
Following CLP, the ApoE−/− mice had a delayed return
to activity and failed to thrive compared to the sham-
treated group (Figure 2). CLP mice were less active in
the first 2 weeks after surgery compared to the sham-
operated groups (8+/−0 vs. 5.1+/−0.4 Activity Composite
Index for sham vs. CLP; P < 0.001), but the activity was
not different between the groups by 3 months. Weight
gain, however, remained different up to 5 months, when
the CLP group had lost 6% of body weight compared to a
9% gain among the sham-operated mice (P < 0.001).
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The aortic atheroma burden in the descending aorta in-
creased over the course of the experimental period in both
the sham- and CLP-treated ApoE−/− mice, but it was more
pronounced in the CLP-treated animals at both 3 months
(20% vs. 29.2% of total aortic surface area; P = 0.03) and
5 months (28.1% vs. 39.7% of total aortic surface area;
P = 0.004) after surgery (Figure 3A). Similarly, CLP
mice at 3 months had an increased atheroma burden at
the aortic root (0.129 mm2 vs. 0.263 mm2; P = 0.03). By
5 months, the unadjusted atheroma burden was 0.31 mm2
in sham-operated mice and 0.197 mm2 in the CLP mice
(P = 0.006), but, normalized for weight, it was higher in
the CLP group (11.6 μm2/mg vs. 20.1 μm2/mg; P = 0.005)
(Figure 3B). Collagen deposition was similar in both
sham- and CLP-treated animals at 5 months (38.5% vs.
54.3% of atheroma plaque area for sham vs. CLP; P >
0.05) (see Additional file 2), but macrophage infiltrationFigure 3 Atheroma burden in the descending aorta and aortic root in
(A) Representative images of descending aorta with atheroma burden. The
5 months (5 m) after surgery. (B) Representative images of aortic root athe
time-matched sham-treated groups. CLP, Cecal ligation and puncture.was significantly elevated at 5 months in the CLP group
(0.52 vs. 0.96 relative fluorescence units; P = 0.038)
(Figure 4).Long-term effects of sepsis on circulating inflammatory
markers
All peritoneal cultures at 3 and 5 months were sterile in
both CLP- and sham-operated ApoE−/− mice. As shown
in Figure 5, the proinflammatory cytokines TNF-α and
IL-6 were higher on day 1 in the CLP group (TNF-α:
5.8 pg/ml vs. 36.9 pg/ml, P = 0.002; IL-6: 16.4 pg/ml vs.
138.7 pg/ml, P < 0.001 (both for sham vs. CLP)), though
IL-10 was not different (4.8 pg/ml vs. 13.9 pg/ml, P = 0.07).
Several cytokines remained elevated up to 5 months (IL-6:
13.06 pg/ml vs. 65.3 pg/ml, P = 0.005; IL-10: 9.13 pg/ml vs.
37.11 pg/ml, P = 0.035 (both for sham vs. CLP)), although
TNF-α and MCP-1 were no longer different.association with sepsis and duration of chronic inflammation.
atheroma burden was recorded at 1 day, 3 months (3 m) and
roma burden at similar time points. *P < 0.05 compared to the
Figure 4 Aortic root macrophage infiltration by 5 months suggestive of chronic inflammatory cell infiltration into the plaques. Macrophages
are shown in red and nuclear material in blue (4′,6-diamidino-2-phenylindole dihydrochloride (DAPI)). The relative fluorescence (rfu) per atheroma is
presented at the 5-month time point (*P < 0.05). CLP, Cecal ligation and puncture.
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and function in the aorta
In the WT mice, the CLP-treated group showed elevated
gene expression of proinflammatory cytokines compared
to the sham-operated group (Figure 6A). TNF-α was up-
regulated 4.7-fold on day 3 (P = 0.014) and 2.7-fold onFigure 5 The changes in the circulating cytokine levels at 1 day, 3 mo
mice. The cytokines were tumor necrosis factor α (TNF-α), interleukin (IL-6)
compared to the time-matched sham-operated group. CLP, Cecal ligationday 5 (P = 0.047), and the chemokine CCL2 was upregu-
lated 6.1-fold on day 3 (P = 0.002) and 5.4-fold on day
5 (P < 0.001). Similarly, adhesion molecules were up-
regulated in the CLP group. ICAM-1 was upregulated
2.9-fold on day 1 (P = 0.01) and 2.3-fold on day 5 (P =
0.006). VCAM-1 gene expression was also upregulated,nths and 5 months after surgery in apolipoprotein E–deficient
and IL-10 and monocyte chemotactic protein 1 (MCP-1). *P < 0.05
and puncture.
Figure 6 (See legend on next page.)
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Figure 6 Changes in aortic root and aortic arch mRNA expression for cytokines and adhesion molecules (tumor necrosis factor α,
chemokine (C-C motif) ligand 2, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1) determined using RT-PCR in
wild-type mice. (A) Relative expression at days 1, 3 and 5 days are presented. CCL2, Chemokine (C-C motif) ligand 2; CLP, Cecal ligation and
puncture; TNF-α, Tumor necrosis factor α. Immunofluorescent images of the aortic root obtained to determine the expression of adhesion molecules
intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) (left to right: secondary antibody–only control, sham, cecal
ligation and puncture (CLP)). ICAM-1 is shown in green, VCAM-1 in red and nuclear material in blue (4′,6-diamidino-2-phenylindole dihydrochloride
(DAPI)). Inset shows possible colocalization of ICAM-1 with VCAM-1. (B) Graph presents cell adhesion to inflamed aortic endothelium at days 1, 3 and
5 days. Representative images show monocyte adhesion to the endothelium by day 5 (*P < 0.05 compared to the time-matched sham-treated groups).
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(P < 0.001). Similar to the gene expression patterns,
staining for ICAM-1 on endothelial luminal surfaces was
prominent by day 5 compared to days 1 and 3 (Figure 6).
VCAM-1 was also upregulated by day 5 and occasionally
colocalized with ICAM-1 by day 5 (Figure 6A, inset).
Using the functional ex vivo assay of endothelial activa-
tion, the CLP-treated mice had 1.7-fold higher monocyte
adhesion by 3 days and 2.62-fold higher adhesion by 5 days
(P = 0.03) (Figure 6B).
Discussion
In this article, we present a combined approach used to in-
terrogate whether acute sepsis accelerates chronic athero-
genesis. We show that mice with preexisting atherosclerosis
randomly allocated to a sepsis group had prolonged in-
flammation, increased atheroma burden, and greater
macrophage infiltration into atheromatous plaques than
sham-operated controls. Additionally, we show that sepsis
induces acute inflammation in aortic tissues, increases
endothelial monocyte adhesion and elevates markers of
vascular inflammation [22]. This work suggests that, at
least in a murine model, sepsis plays a causal role in ac-
celerating both the total burden of atheroma and the
infiltration of inflammatory cells into the plaques, pos-
sibly making the plaques more vulnerable to rupture.
Importantly, the persistent effects did not appear to be
due to ongoing infection. Thus, it seems probable that
the accelerated atheroma is due to persistence of a local
or systemic host inflammatory response.
Critical illness has long-lasting effects that continue be-
yond the time of hospitalization [23]. We and others have
previously shown that cardiovascular disease is a leading
cause of rehospitalization after community-acquired pneu-
monia (CAP), occurring in 19% over the course of 5 years
[24]. Interestingly, only 23% of those who developed a car-
diovascular event after severe sepsis had a prior history of
clinically overt cardiovascular disease. In a separate cohort,
CAP survivors had unresolved inflammation at hospital
discharge despite being deemed ready for discharge, and
higher IL-6 levels were associated with higher risk of car-
diovascular disease–related deaths during the subsequent
year [6]. As short-term mortality continues to decline withadvances in critical care, there is an increasing focus on
long-term morbidity and mortality. Our work suggests a
causal role for sepsis in aggravating cardiovascular disease
and thus raises the possibility of studying interventions in
preclinical as well as clinical models and considering car-
diovascular disease endpoints in sepsis trials.
Failure to gain weight or weight loss has been reported
in previous murine sepsis studies, but only for shorter
time horizons [25,26]. We were therefore intrigued by our
finding of persistent failure to gain weight. Anorexia and
weight loss are common in critical illness, prompting cli-
nicians to engage in aggressive attempts to feed pa-
tients. Yet, weight loss has lowered atherosclerotic
burden in both clinical and preclinical studies [27-29],
whereas weight gain promotes atheroma [30]. Recently,
King et al. demonstrated that atheroma burden grew in
parallel with weight gain over a 24-week course in
ApoE−/− mice fed a high-fat diet [10]. Thus, both sepsis
and weight gain promote atheroma. Consequently, had
we been able to feed the mice enough to promote
weight gain post-CLP treatment, the acceleration in
atheroma may have been even worse. Furthermore, one
wonders whether the anorexia following critical illness
could have protective effects that are undermined by
aggressive feeding practices.
There are several important considerations when
interpreting our findings. First, to achieve our goal of
testing for the effects of sepsis on cardiovascular disease,
we had to forge a balanced combination of existing
models. Combining the models required extensive pilot
work to titrate the severity of the sepsis insult such that
the animals were rendered appropriately sick, reflective
of sepsis, and yet still likely to have high short-term sur-
vival with antibiotics and fluid resuscitation. Thus, for
pragmatic reasons, we considered only one model of
atherosclerosis and one model of sepsis [10,25].
Although we show a persistence of IL-6 and IL-10 ele-
vations, their role in inflammation should be evaluated
within the context of the stage of sepsis. IL-10 has been
assigned a regulatory role, which, early in the course of
sepsis, could improve the outcome, whereas it may be
deleterious late in the course of sepsis, suggesting a di-
chotomous role for this cytokine [31,32].
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though a WT model would have been ideal, it is hard to
induce atheroma in such animals. ApoE−/− mice are prone
to atheroma when fed a high-fat diet. However, obtaining,
feeding and housing these mice for many months is ex-
pensive. Furthermore, knocking out ApoE could confound
interpretation of the link between inflammation and ather-
oma, as ApoE modulates the type I inflammatory response
and ApoE polymorphisms are associated with sepsis sus-
ceptibility and outcomes [33,34]. These reasons influenced
our decision to use WT mice to assess acute inflammatory
changes. To show additional parameters of inflammation,
we will incorporate plasminogen activator inhibitor 1 and
fibrinogen levels in future studies.
Ideally, we would have studied plaque rupture and
thrombosis, but these events are rare in murine ather-
oma models. A brachiocephalic artery model or a cross
between the ApoE−/− mice and mice deficient in recep-
tor class B, type I has promising results mimicking hu-
man disease and may be a better choice in future studies
[35]. CLP is one of the most common models of sepsis,
but may be indicative only of intra-abdominal sepsis.
We do not know if alternative sepsis models, such as in-
stallation pneumonia models, would result in similar
long-term effects. The optimal duration of follow-up is
also unclear, although 5 months appeared adequately
long to capture a variety of clinical and pathophysio-
logic changes. Additionally, extrapolating any murine
data to humans requires caution, given poor cross-
species correlation of the host response to infection
and injury [36].
The purpose of this study was to determine whether
sepsis plays a causal role in accelerating atheroma. How-
ever, the goal was not to determine the exact mechanism
by which sepsis promotes atheroma. CLP induces a
massive and complex host response, and the CLP insult
itself, although a standardized injury, likely results in a
variable pathogen load across animals. Thus, the number
of plausible molecular and cellular pathways that could
underlie the sepsis effects is huge, and their elucidation
is beyond the scope of this article. Nevertheless, this
model can serve as a translational tool when evaluating
whether future therapies can modulate these late effects
of sepsis.Conclusions
We developed a murine acute and chronic model com-
bining abdominal sepsis and atherosclerosis mimicking
patients surviving sepsis and succumbing to its down-
stream effects on atherosclerosis [37]. This model could
be used to dissect the molecular mechanisms and test
therapeutic strategies to improve long-term outcomes of
sepsis.Key messages
 Acute sepsis preclinical models do not capture
chronic changes; therefore, models mimicking
long-term outcomes from sepsis are required to
study human disease.
 We developed both acute and chronic sepsis
survival models in mice to study vascular
inflammation and progression of atherosclerosis.
 In a 5-day acute model, we show that the aorta
becomes a site of inflammation with increased
expression of ICAM-1, TNF-α, CCL2 and VCAM-1,
as well as increased adhesion of monocytic cells to
the endothelium.
 In the chronic model, which lasted for up to
9 months, we used atherosclerosis-prone ApoE−/−
mice. Over the course of the experimental period,
sepsis-surviving mice had increased systemic
inflammation and atheroma burden, whereas
peritoneal bacterial cultures remained negative.
 In this study, we developed a chronic sepsis survival
model with persistent inflammation and
atherosclerosis in mice, making it possible to study
clinically relevant questions in a preclinical model.
Additional files
Additional file 1: Preliminary survival analysis with varying needle
sizes. There was only one dead mouse 7 days after CLP with a 25-gauge
needle.
Additional file 2: Collagen staining in the aortic root in association
with sepsis on day 1 and at 3 and 5 months. Bottom, representative
images of aortic root collagen staining at 5 months.
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